Pioneer in clinical pharmacology will be deeply missed
The MMV team mourns the loss of Professor Sir Colin Dollery, a longtime MMV collaborator and a pioneer in the field of clinical pharmacology. Sir Colin passed away peacefully on 12 December 2020.
Sir Colin is most known for his work in the field of cardiovascular pharmacology, but he also played a crucial role in the fight against malaria. He strongly advocated the moral obligation of the global health community to pregnant women in malaria-endemic regions, who have a considerably higher risk of being affected by malaria due to the lack of treatment options available to them.
He supported MMV for over a decade through his position on the MMV Global Safety Board (GSB) from 2007 to 2018. “Sir Colin had a wealth of experience and knowledge in all areas of medicine including clinical development, infectious diseases, malaria regulatory systems, and ethics and toxicology. He was a walking medical encyclopedia,” said Dr Stephan Duparc, MMV’s Chief Medical Officer. “When a project had been reviewed by Sir Colin, we knew it was in extremely good hands.”
Prior to joining the pharmaceutical industry with SmithKline Beecham (now known as GlaxoSmithKline or GSK) in 1996, Sir Colin was the Chairman of Medicine at the Royal Postgraduate Medical School, London.
In recognition of his work in establishing the discipline of clinical pharmacology in Europe, he was knighted by the Queen in 1987. Furthermore, Sir Colin was the beneficiary of the Lilly Prize in 1983, the Wellcome Gold Medal in 2007, and the European Association for Clinical Pharmacology and Therapeutics (EACTP) Lifetime Award in 2011. Among his other recognitions, Sir Colin was the Founding Chairman of the Clinical Pharmacology Section of the British Pharmacological Society and a Fellow of the Academy of Medical Sciences.
The field of clinical pharmacology will be forever indebted to Sir Colin and his invaluable contributions.
The MMV team extends their deepest condolences to Sir Colin’s family, friends, and colleagues. He will be missed, not least for his knowledge, wisdom, and foresight.